KRAS and neoplasm: Our laboratory previously reported that mice with systemic (germline) deletion of p38δ were resistant to chemically-induced skin tumorigenesis and to oncogenic K-ras-driven lung tumorigenesis, indicating that p38δ promotes tumor development in vivo [11].